227 related articles for article (PubMed ID: 23991314)
1. The development of targeted therapy in small cell lung cancer.
Zhang Y; He J
J Thorac Dis; 2013 Aug; 5(4):538-48. PubMed ID: 23991314
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in small cell lung cancer: a review.
Abidin AZ; Garassino MC; Califano R; Harle A; Blackhall F
Ther Adv Med Oncol; 2010 Jan; 2(1):25-37. PubMed ID: 21789124
[TBL] [Abstract][Full Text] [Related]
3. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies in small cell lung cancer.
Lu HY; Wang XJ; Mao WM
Oncol Lett; 2013 Jan; 5(1):3-11. PubMed ID: 23255884
[TBL] [Abstract][Full Text] [Related]
5. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
6. Targeted drugs in small-cell lung cancer.
Santarpia M; Daffinà MG; Karachaliou N; González-Cao M; Lazzari C; Altavilla G; Rosell R
Transl Lung Cancer Res; 2016 Feb; 5(1):51-70. PubMed ID: 26958493
[TBL] [Abstract][Full Text] [Related]
7. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
8. Second-line chemotherapy for small-cell lung cancer (SCLC).
Kim YH; Mishima M
Cancer Treat Rev; 2011 Apr; 37(2):143-50. PubMed ID: 20580163
[TBL] [Abstract][Full Text] [Related]
9. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in the treatment of small cell lung cancer.
Tartarone A; Giordano P; Lerose R; Rodriquenz MG; Conca R; Aieta M
Med Oncol; 2017 Jun; 34(6):110. PubMed ID: 28456992
[TBL] [Abstract][Full Text] [Related]
11. Current status of clinical trials for small cell lung cancer.
Fischer B; Arcaro A
Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
13. [Highlights of PAPR Inhibitors in Small Cell Lung Cancer].
Zhang S; Liu J; Yang C; Zhang L; Li S; Bao H; Cheng Y
Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):806-810. PubMed ID: 32752582
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
15. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
Fischer B; Marinov M; Arcaro A
Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy versus best supportive care for extensive small cell lung cancer.
Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Nov; (11):CD001990. PubMed ID: 24282143
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
Gadgeel SM
Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
[TBL] [Abstract][Full Text] [Related]
18. PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches.
Barayan R; Ran X; Lok BH
J Thorac Dis; 2020 Oct; 12(10):6240-6252. PubMed ID: 33209463
[TBL] [Abstract][Full Text] [Related]
19. Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.
Sen T; Gay CM; Byers LA
Transl Lung Cancer Res; 2018 Feb; 7(1):50-68. PubMed ID: 29535912
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC).
Deneka AY; Boumber Y; Beck T; Golemis EA
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31484422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
